More Business Wire
View Older Stories View Newer Stories-
Sam’s Club Launches Member-Inspired, Chef-Crafted Thanksgiving Feast — Ready in Under Two Hours for Under $100*
-
Ovadiah Jacob Joins Evercore as Senior Managing Director in the Private Capital Markets Group
-
Super Group to Report Third Quarter 2025 Financial Results
-
Eyelit Technologies Recognized as a Major Player in the 2025 IDC MarketScape for Worldwide Advanced Planning and Scheduling (APS) Software Providers
-
bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025
-
Valink Therapeutics Closes $11.8 Million Pre-A Financing Round to Advance Oncology Pipeline
-
Axos Financial, Inc. Named to Fortune’s Top 100 Fastest-Growing Companies
-
Innoviva Specialty Therapeutics Announces Oral Presentation Featuring New Analyses from the Zoliflodacin Pivotal Phase 3 Trial at IDWeek 2025
-
Kivu Bioscience Presents Preclinical Data for KIVU-107 Demonstrating Potent and Durable Anti-Tumor Activity and a Wide Therapeutic Index at World ADC San Diego 2025
-
Applebee’s® Announces Return of FREE Boneless Wings on Halloween for Online Orders
-
Redfin Reports Homebuyers Are Scoring the Biggest Autumn Discounts Since 2019
-
Axos Bank Named MONEY’s Best Banks for 2025
-
Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities
-
Proof Launches Digital Credential Solution to Power Modern Compliance for Digital Asset Services
-
Regan Total Return Income Fund (RCIRX) Celebrates Five-Year Anniversary
-
ShopOne and its JV Partners Expand Atlanta Portfolio with Acquisition of Publix-anchored Stockbridge Lakes
-
Donaldson Capital Management Named One of America’s Top 250 RIA Firms by Forbes for Second Consecutive Year
-
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer
-
Farmers & Merchants Bank of Long Beach Closes Equity Investment
-
Surescripts Touchless Prior Authorization Surpasses 76,000 Prescribers, Ushering in a New Era of Medication Access
-
Clarametyx Biosciences Strengthens Leadership Team to Accelerate Pipeline and Corporate Development Progress
-
AI-Driven Cyber Threats Are the Biggest Concern for Cybersecurity Professionals Going Into 2026, Finds New ISACA Research
-
Belgard® Showcases Award-Winning Outdoor Living Solutions at Hardscape North America
-
New Data Show Early Use of Delve Bio’s Metagenomic Testing Can Reduce Need for Conventional Tests and Overall Length of Stay for Patients with Meningitis/Encephalitis
-
UBS Hires Financial Advisor Michael Shain in Greenville, South Carolina
-
Royal Gold Completes Sandstorm Gold and Horizon Copper Acquisitions to Create a Premier Growth Company in the Gold Streaming and Royalty Sector
-
Stoke Therapeutics Presents Two-Year Natural History Data from Patients with Autosomal Dominant Optic Atrophy (ADOA)
-
STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025
-
Viridian Therapeutics Announces Royalty Financing with DRI Healthcare for up to $300 Million
-
Lineage Announces New Chief Financial Officer
-
Aramark to Host Conference Call on Fourth Quarter and Full Year Fiscal 2025 Results
-
Teledyne FLIR Defense to Deliver Portable Chemical Detectors to US Customs and Border Protection to Aid in Narcotics Crackdown
-
Advanced Infusion Care (AIC) Now Offers Kedrion Biopharma’s YIMMUGO® (Immune Globulin Intravenous Human-Dira, 10% Liquid)
-
Cooler Master Expands Its Thermal Excellence with Hyper 212 3DHP Series and V4 Alpha 3DHP Black
-
IonQ Partners with Italy’s National Strategy for Quantum Technology; Co-Founds Q-Alliance to Jointly Create Quantum Hub
-
Alto Neuroscience Announces $50 Million Private Placement Financing
-
Alto Neuroscience Announces Plans to Accelerate Development of ALTO-207 in Treatment Resistant Depression Following Successful Outcome from Recent FDA Meeting
-
Enanta Pharmaceuticals Presents New Data for Zelicapavir, its N-Protein Inhibitor, and EDP-323, its L-Protein Inhibitor, Both in Development for the Treatment of Respiratory Syncytial Virus (RSV) at I
-
Glaukos Announces FDA Approval of Epioxa™
-
Fanatec Powers Sim Racers with Launch of Highly Anticipated Products at SimRacing Expo 2025
-
Spanish Mountain Gold Initiates Ore Sorting Work on Gold Mineralization
-
Iambic Shares Clinical Data from Ph1/1B Study of IAM1363, a Highly Selective Type-2 HER2 Inhibitor, Demonstrating Monotherapy Activity in Heavily Pretreated Patients with HER2 Alterations, at the 2025
-
NPK International Announces Third Quarter 2025 Results Conference Call and Webcast Date
-
Covalon to Participate in the Planet MicroCap Showcase: TORONTO on October 22, 2025
-
Old Dominion Freight Line, Inc. Announces General Rate Increase
-
Lattice Semiconductor Schedules Third Quarter 2025 Results Conference Call
-
KKR Launches Galaxy Container Solutions, A Global Container Leasing and Financing Platform
-
Worldpay Signs Exclusive Agreement to Power Kroger’s Payment Processing
-
Aqua Pennsylvania Awarded $35 Million in PENNVEST Funding for PFAS Treatment at Delaware County Water Plant
